Copper and Cu NanoParticles / cycD1/CCND1 Cancer Research Results

Cu, Copper and Cu NanoParticles: Click to Expand ⟱
Features:
Copper
Metal
Copper levels are considerably elevated in various malignancies.
Copper [Cu(II)] is a transition and trace element in living organisms. It increases reactive oxygen species (ROS) and free-radical generation that might damage biomolecules like DNA, proteins, and lipids.

Copper (dietary/physiology) ≠ copper-loading therapeutics ≠ copper nanoparticles.
For Cu nanoparticles, the dominant and most reproducible theme is toxicity via ROS → mitochondrial damage/genotoxicity, not clean tumor selectivity.
- Copper acts as a critical cofactor for numerous enzymes involved in redox reactions, energy production, and connective tissue formation.
- Increased copper levels in the tumor microenvironment can enhance angiogenic signaling and thus supply the tumor with necessary oxygen and nutrients, facilitating tumor growth and metastasis.
- Copper can participate in redox cycling reactions, similar to the Fenton reaction, leading to the production of reactive oxygen species (ROS).
- Cancer cells often exhibit altered copper homeostasis, with some studies showing elevated copper levels in tumor tissues relative to normal tissues.

Two main approaches are:
- Copper Chelation: Drugs that bind copper (chelators) can reduce the bioavailability of copper, potentially inhibiting angiogenesis and other copper-dependent tumor processes.
- Copper Ionophores: These agents facilitate the transport of copper into cancer cells to induce cytotoxicity by elevating intracellular copper levels beyond a tolerable threshold, leading to cell death.

- Depletion of glutathione and stimulation of lipid peroxidation, catalase and superoxide dismutase.
- Studies have shown that the level of copper in tumour cells and blood serum from cancer patients is elevated, and the conclusion is that cancer cells need more copper than healthy cells. (but also sometimes depleted).
- Copper is a double-edged sword, maintaining normal cell development and promoting tumor development.
- Tumor tissue has a higher demand for copper and is more susceptible to copper homeostasis, copper may modulate cancer cell survival through reactive oxygen species (ROS) excessive accumulation, proteasome inhibition and anti-angiogenesis.

Natural Product: Cu, Copper (ion biology)
Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Cuproptosis (copper-triggered mitochondrial cell death) Cu accumulation → binding to lipoylated TCA proteins → aggregation; Fe–S proteins ↓; proteotoxic stress ↑ Tight copper homeostasis usually prevents this R, G Regulated cell death (mitochondria-linked) Cuproptosis is a distinct copper-dependent death pathway tied to mitochondrial metabolism and lipoylated TCA components. :contentReference[oaicite:0]{index=0}
2 Copper homeostasis machinery (transport/chaperones) Copper trafficking affects tumor programs (growth/metastasis; context) Essential micronutrient; homeostasis prevents toxicity R, G Homeostasis / signaling coupling Copper import/export and chaperones couple copper availability to signaling and phenotype; dysregulation is increasingly discussed in cancer biology. :contentReference[oaicite:1]{index=1}
3 Angiogenesis support (copper-dependent tumor vascularization) Pro-angiogenic tone supported by copper availability (context) Physiologic angiogenesis/wound repair support G Vascular program modulation Copper deficiency/chelation has been reported to impair tumor angiogenesis in preclinical/clinical contexts. :contentReference[oaicite:2]{index=2}
4 LOX/LOXL family (ECM remodeling; copper-dependent enzymes) ECM crosslinking / invasion-metastasis programs ↑ (context) Normal ECM maturation and tissue repair G Microenvironment remodeling LOX enzymes are copper-dependent and implicated in tumor stroma remodeling and metastatic niche biology. :contentReference[oaicite:3]{index=3}
5 ROS / redox chemistry (Cu redox cycling) Oxidative stress ↑ (context); DNA/protein damage ↑ Redox enzyme cofactor; excess is toxic P, R, G Stress amplification (conditional) Copper can catalyze redox reactions; whether this is tumor-selective depends on copper handling, antioxidants, and exposure context.
6 Copper ionophores / copper-loading strategies (research/therapy concept) Intracellular Cu ↑ → stress/death programs ↑ (context) — R, G Therapeutic lever (conceptual) Reviews discuss copper ionophores as tools to drive copper accumulation and explore cuproptosis/ROS mechanisms; clinical positioning varies. :contentReference[oaicite:4]{index=4}
7 Copper chelation (anti-angiogenic / microenvironment strategy) Angiogenesis and tumor progression pressure ↓ (context) Risk of deficiency if excessive G Translation/strategy axis Tetrathiomolybdate and related chelation strategies have been studied clinically as anti-angiogenic approaches. :contentReference[oaicite:5]{index=5}

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid redox interactions)
  • R: 30 min–3 hr (acute mitochondrial/proteotoxic stress signaling)
  • G: >3 hr (gene-regulatory adaptation and phenotype outcomes)

Copper Nanoparticles: CuNP / CuO-NP (tox + “anticancer” claims are mostly preclinical)
Rank Axis Cell/Tumor Context Whole-Body / Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Oxidative stress (ROS generation) + antioxidant depletion ROS ↑; lipid peroxidation ↑; DNA damage ↑ (reported) Liver/kidney oxidative injury risk ↑ in animal studies P, R, G Primary toxicity driver CuO nanoparticles are widely reported to cause cytotoxicity primarily via oxidative stress leading to genotoxicity. :contentReference[oaicite:6]{index=6}
2 Mitochondrial dysfunction ΔΨm ↓; ATP ↓; apoptosis signaling ↑ (reported) Organ toxicity links include mitochondrial impairment R, G Energy failure / apoptosis coupling Mitochondria-mediated apoptosis has been reported with CuO NPs in cell models (e.g., HepG2). :contentReference[oaicite:7]{index=7}
3 Inflammation / immune activation Inflammatory signaling ↑ (context) Inflammation contributes to organ injury in vivo R, G Tissue injury amplification Sub-chronic exposure reviews describe inflammation as part of CuNP/CuO-NP toxicity patterns. :contentReference[oaicite:8]{index=8}
4 Genotoxicity DNA strand breaks ↑; chromosomal damage ↑ (reported) Potential long-term risk signal (model-dependent) R, G Genome damage Often downstream of ROS; repeatedly reported across CuO NP toxicity literature. :contentReference[oaicite:9]{index=9}
5 “Anticancer” cytotoxicity claims (preclinical) Viability ↓ in various cell lines (often at high concentrations) Translation limited by toxicity and exposure constraints G Non-selective cytotoxicity risk Many studies show tumor cell killing, but often at concentrations that also harm normal cells; selectivity is a major issue. :contentReference[oaicite:10]{index=10}
6 Reproductive/developmental toxicity signals (animal models) — Reported reproductive system impacts in animal studies G Safety constraint Recent studies discuss reproductive toxicity and mitochondrial injury in germline cells with CuO NPs. :contentReference[oaicite:11]{index=11}

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid ROS/redox interactions at particle surfaces)
  • R: 30 min–3 hr (mitochondrial stress + inflammatory signaling)
  • G: >3 hr (genotoxicity, apoptosis, organ-level outcomes)
cycD1/CCND1, cyclin D1 pathway: Click to Expand ⟱
Source:
Type:
Also called CCND1 Gatekeeper of Cell-Cycle Commitment
The main function of cyclin D1 is to maintain cell cycle and to promote cell proliferation. Cyclin D1 is a key regulatory protein involved in the cell cycle, particularly in the transition from the G1 phase to the S phase. It is part of the cyclin-dependent kinase (CDK) complex, where it binds to CDK4 or CDK6 to promote cell cycle progression.
Cyclin D1 is crucial for the regulation of the cell cycle. Overexpression or dysregulation of cyclin D1 can lead to uncontrolled cell proliferation, a hallmark of cancer.
Cyclin D1 is often found to be overexpressed in various cancers.
Cyclin D1 can interact with tumor suppressor proteins, such as retinoblastoma (Rb). When cyclin D1 is overexpressed, it can lead to the phosphorylation and inactivation of Rb, releasing E2F transcription factors that promote the expression of genes required for DNA synthesis and cell cycle progression.
Cyclin D1 is influenced by various signaling pathways, including the PI3K/Akt and MAPK pathways, which are often activated in cancer.
In some cancers, high levels of cyclin D1 expression have been associated with poor prognosis, making it a potential biomarker for cancer progression and treatment response.
Scientific Papers found: Click to Expand⟱
5012- DSF,  Cu,    Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
ROS↑, ALDH↓, TumCP↓, CSCs↓, angioG↓, TumMeta↓, DNAdam↑, Proteasome↓, SOD1↓, GSR↓, ox-GSSG↑, GSH/GSSG↓, MMP↓, Akt↓, cycD1/CCND1↓, NF-kB↓, CSCs↓, MAPK↓, angioG↓, DrugR↓, EMT↓, Vim↓, BioAv↑, eff↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

GSH/GSSG↓, 1,   GSR↓, 1,   ox-GSSG↑, 1,   ROS↑, 1,   SOD1↓, 1,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 1,  

Cell Death ⓘ

Akt↓, 1,   MAPK↓, 1,   Proteasome↓, 1,  

DNA Damage & Repair ⓘ

DNAdam↑, 1,  

Cell Cycle & Senescence ⓘ

cycD1/CCND1↓, 1,  

Proliferation, Differentiation & Cell State ⓘ

ALDH↓, 1,   CSCs↓, 2,   EMT↓, 1,  

Migration ⓘ

TumCP↓, 1,   TumMeta↓, 1,   Vim↓, 1,  

Angiogenesis & Vasculature ⓘ

angioG↓, 2,  

Immune & Inflammatory Signaling ⓘ

NF-kB↓, 1,  

Drug Metabolism & Resistance ⓘ

BioAv↑, 1,   DrugR↓, 1,   eff↑, 1,  
Total Targets: 22

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: cycD1/CCND1, cyclin D1 pathway
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:64  Target#:73  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page